LON:HCM HUTCHMED (HCM) Share Price, News & Analysis GBX 217 -6.00 (-2.69%) As of 12:42 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsNews and Trends About HUTCHMED Stock (LON:HCM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get HUTCHMED alerts:Sign Up Key Stats Today's Range 217▼ 221.1650-Day Range 192▼ 22852-Week Range 150.48▼ 239Volume5,796 shsAverage Volume37,389 shsMarket Capitalization£1.89 billionP/E Ratio108.50Dividend Yield4.63%Price TargetN/AConsensus RatingN/A Company Overview We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13). Read More Receive HCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HUTCHMED and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HCM Stock News HeadlinesHUTCHMED Announces Expanded NRDL Coverage For ELUNATE And ORPATHYS In ChinaNovember 16 at 7:19 AM | rttnews.comHUTCHMED Announces 2027 China NRDL Inclusion and Renewal for ELUNATE, ORPATHYS and SULANDANovember 15 at 11:11 PM | quiverquant.comQMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 17 at 1:00 AM | Weiss Ratings (Ad)HUTCHMED (China) (HCM) Gets a Buy from Orient SecuritiesNovember 8, 2026 | theglobeandmail.comHUTCHMED (AIM:HCM) Stock May Look Rich As FDA Orphan Drug News LandsNovember 2, 2026 | finance.yahoo.comHUTCHMED Advances ORPATHYS-TAGRISSO Through EU, Japan ReviewsNovember 2, 2026 | rttnews.comHUTCHMED's Sovleplenib Receives U.S. FDA Orphan Drug Designation For ITPOctober 28, 2026 | rttnews.comHUTCHMED Announces FDA Orphan Drug Designation for Sovleplenib in Primary Immune ThrombocytopeniaOctober 28, 2026 | quiverquant.comQSee More Headlines HCM Stock Analysis - Frequently Asked Questions How have HCM shares performed this year? HUTCHMED's stock was trading at GBX 209 at the beginning of the year. Since then, HCM shares have increased by 3.8% and is now trading at GBX 217. How do I buy shares of HUTCHMED? Shares of HCM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of HUTCHMED own? Based on aggregate information from My MarketBeat watchlists, some other companies that HUTCHMED investors own include BAE Systems (BA), Barclays (BARC), The Berkeley Group (BKG), BP (BP), Diageo (DGE), Domino's Pizza Group (DOM) and Glencore (GLEN). Industry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolLON:HCM CIKN/A Webwww.chi-med.com Phone+85221213888FaxN/AEmployees1,760Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 2 Trailing P/E Ratio108.50 Forward P/E RatioN/A P/E GrowthN/ANet Income-£52.98 million Net Margins163.84% Pretax MarginN/A Return on Equity18.42% Return on Assets-5.90% Debt Debt-to-Equity Ratio7.91 Current Ratio4.96 Quick Ratio2.97 Sales & Book Value Annual Sales£549.12 million Price / Sales3.43 Cash FlowGBX 86.98 per share Price / Cash Flow2.49 Book ValueGBX 87.44 per share Price / Book2.48Miscellaneous Outstanding Shares869,071,000Free FloatN/AMarket Cap£1.89 billion OptionableNot Optionable Beta0.43 The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (LON:HCM) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.